The current price-to-earnings ratio of KNSA can't be determined, as the TTM EPS of -$0.13 is negative. The most recent PE ratio recorded for Kiniksa Pharmaceuticals was 164.42 in March 2024.
Over the last three years, the average PE ratio of Kiniksa Pharmaceuticals has been 45.35. In the past three years, KNSA's PE ratio was at its highest in the Mar 2024 quarter at 164.42, with a price of $19.73 and an EPS of $0.12. The Mar 2023 quarter recorded the bottom point at 3.82, with a price of $10.76 and an EPS of $2.82.
Maximum annual increase: 1,446.74% in 2023
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2023 | 87.7 | 1,446.74% | $17.54 | $0.2 |
2022 | 5.67 | N/A | $14.98 | $2.64 |
2021 | N/A | N/A | $11.77 | -$2.3 |
2020 | N/A | N/A | $17.67 | -$2.61 |
2019 | N/A | N/A | $11.06 | -$2.99 |
2018 | N/A | N/A | $28.09 | -$3.49 |
2017 | N/A | N/A | N/A | -$35.85 |
2016 | N/A | N/A | N/A | -$91.61 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Sep 2024 | N/A | N/A | $24.99 | -$0.13 |
Jun 2024 | N/A | N/A | $18.67 | -$0.15 |
Mar 2024 | 164.42 | 87.48% | $19.73 | $0.12 |
Dec 2023 | 87.7 | N/A | $17.54 | $0.2 |
Sep 2023 | N/A | N/A | $17.37 | -$0.11 |
Jun 2023 | 4.24 | 10.99% | $14.08 | $3.32 |
Mar 2023 | 3.82 | -32.63% | $10.76 | $2.82 |
Dec 2022 | 5.67 | -8.99% | $14.98 | $2.64 |
Sep 2022 | 6.23 | N/A | $12.84 | $2.06 |
Jun 2022 | N/A | N/A | $9.69 | -$1.61 |
Mar 2022 | N/A | N/A | $9.94 | -$1.93 |
Dec 2021 | N/A | N/A | $11.77 | -$2.3 |
Sep 2021 | N/A | N/A | $11.39 | -$2.58 |
Jun 2021 | N/A | N/A | $13.93 | -$2.8 |
Mar 2021 | N/A | N/A | $18.51 | -$2.84 |
Stock name | PE ratio | Market cap |
---|---|---|
ORMP Oramed Pharmaceuticals Inc | 23.64 | $104.81M |
OLMA Olema Pharmaceuticals Inc | N/A | $299.09M |
OMER Omeros Corp | N/A | $505.32M |
OMGA Omega Therapeutics Inc | N/A | $10.7M |
ONVO Organovo Holdings Inc | N/A | $5.32M |
ORIC Oric Pharmaceuticals Inc | N/A | $695.08M |
KNSA Kiniksa Pharmaceuticals Ltd | N/A | $1.42B |
The current price to earnings ratio of KNSA can't be calculated, as its EPS of -$0.13 is negative.
Over the last 3 years, the average price to earnings ratio for KNSA stock is 45.35.
Over the last 5 years, the average price to earnings ratio for KNSA stock is 45.35.
Over the last three years, the quarterly PE ratio reached a historic high of 164.42 in the Mar 2024 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.